Disruption of the myocardial extracellular matrix leads to cardiac dysfunction.
MMP activity with disruption of structural collagen has been implicated in the pathophysiology of dilated cardiomyopathy. To examine the role of this enzyme in cardiac function, a transgenic mouse was created that constitutively expressed human collagenase (MMP-1) in the heart. At 6 months of age, these animals demonstrated compensatory myocyte hypertrophy with an increase in the cardiac collagen concentration due to elevated transcription of type III collagen. Chronic myocardial expression of MMP-1 produced loss of cardiac interstitial collagen coincident with a marked deterioration of systolic and diastolic function at 12 months of age. This is the first animal model demonstrating that direct disruption of the extracellular matrix in the heart reproduces the changes observed in the progression of human heart failure.
Kim
H E
HE
Division of Molecular Medicine, Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA.
Dalal
S S
SS
Young
E
E
Legato
M J
MJ
Weisfeldt
M L
ML
D'Armiento
J
J
D000367:Age Factors; D000818:Animals; D006332:Cardiomegaly / Q000378:metabolism* / Q000473:pathology; D003094:Collagen / Q000378:metabolism; D003971:Diastole; D005109:Extracellular Matrix / Q000378:metabolism*; D015870:Gene Expression; D006333:Heart Failure / Q000209:etiology*; D006439:Hemodynamics; D006909:Hydroxyproline / Q000032:analysis; D020781:Matrix Metalloproteinase 1 / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D013599:Systole
D003094:Collagen; D020781:Matrix Metalloproteinase 1; D006909:Hydroxyproline